Recognition of early warning signs in patients with schizophrenia: A review of the literature

International Journal of Mental Health Nursing

Volumn 13, Issue 2, 2004, Pages 107-116

  Van Meijel, Berno ^a,b   Van Der Gaag, Mark ^c   Sylvain, René Kahn ^a   Grypdonck, Maria H F ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b INHOLLAND UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^c PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

Author keywords

Early warning signs; Nursing; Prevention; Relapse; Schizophrenia

Indexed keywords

HUMAN; METHODOLOGY; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; NURSING EVALUATION RESEARCH; PREDICTION AND FORECASTING; PSYCHIATRIC NURSING; PSYCHOLOGICAL MODEL; PSYCHOLOGY; RECURRENT DISEASE; REVIEW; SCHIZOPHRENIA; STANDARD; TIME;

HUMANS; MODELS, PSYCHOLOGICAL; NURSE'S ROLE; NURSING ASSESSMENT; NURSING EVALUATION RESEARCH; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC NURSING; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS;

EID: 6944223033     PISSN: 14458330     EISSN: 14400979     Source Type: Journal    
DOI: 10.1111/j.1440-0979.2004.00314.x     Document Type: Review

References (83)

1. American Psychiatric Association (1997). Practice guidelines for the treatment of patients with schizophrenia. American Journal of Psychiatry, 154, 1-63.
2. Ayuso-Gutierrez, J. L. & Rio Vega, J. M. d. (1997). Factors influencing relapse in the long-term course of schizophrenia. Schizophrenia Research, 28, 199-206.
3. Baker, C. (1995). The development of the self-care ability to detect early signs of relapse among individuals who have schizophrenia. Archives of Psijchiatric Nursing, 5, 261-268.
4. Birchwood, M. (1992). Early intervention in schizophrenia: theoretical background and clinical strategies. British Journal of Clinical Psychology, 31, 257-278.
5. Birchwood, M., Macmillan, F. & Smith, J. (1992). Early intervention. In M. Birchwood et al. (Ed.). Innovations in the Psychological Management of Schizophrenia (pp. 115-145). Chichester: J. Wiley & Sons.
6. Birchwood, M., Smith, J., Macmillan, F., Hogg, B., Prasad, R., Harvey, C. & Bering, S. (1989). Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation. Psychological Medicine, 19, 649-656.
7. Birchwood, M. & Spencer, E. (2001). Early intervention in psychotic relapse. Clinical Psychology Review, 21, 1211-1226.
8. Birchwood, M., Spencer, E. & McGovern, D. (2000). Schizophrenia: early warning signs. Advances in Psychiatric Treatment, 6, 93-101.
9. Boevink, W. A., Wolf, J. R. L. M., Nieuwenhuizen, C. & Schene, A. H. (1995). Kwaliteit van leven van langdurig van ambulante zorg afhankelijke psychiatrische patienten; een conceptuele verkenning. [Quality of life of longterm care dependent psychiatric patients; a conceptual exploration]. Tijdschrift Voor Psychiatrie, 2, 97-110 (in Dutch).
10. Boker, W., Brenner, H. D., Wurgler, S. (1989). Vulnerability-linked deficiences, psychopathology and coping behaviour of schizophrenics and their relatives. British Journal of Psychiatry, 155, 128-135.
11. Breier, A. & Strauss, J. S. (1983). Self-control in Psychotic Disorders. Archives of General Psychiatry, 40, 1141-1145.
12. Buchanan, R. W. & Carpenter, W. T. (2000). Schizophrenia: Introduction and Overview. In B. J. Sadock et al. (Ed.). Comprehensive Textbook of Psychiatry (pp. 1096-1110). Philadelphia: Lippincott Williams & Wilkins.
13. Bustillo, J., Buchanan, R. W. & Carpenter, W. T. (1995). Prodromal symptoms vs. early warning signs and clinical action in schizophrenia. Schizophrenia Bulletin, 4, 553-559.
14. Bustillo, J., Keith, S. J. & Lauriello, J. (2000). Schizophrenia: Psychosocial Treatment. In B. J. Sadock et al. (Ed.). Comprehensive Textbook of Psychiatry (pp. 1210-1217). Philadelphia: Lippincott Williams & Wilkins.
15. Campo, J. & Merckelbach, H. (1996). Schizofrene patiënten en haardracht [Schizophrenic patients and hair cut]. Tijdschrift Voor Psychiatrie, 9, 690-694 (in Dutch).
16. Carpenter, W. T., Hanlon, T. E., Heinrichs, D. W. et al. (1990). Continuous versus targeted medication in schizophrenic outpatients: outcome results. American Journal of Psychiatry, 1138-1148.
17. Carpenter, W. T. & Heinrichs, D. W. (1983). Early intervention, time limited, targeted pharmacotherapy of schizophrenia. Schizophrenia Bulletin, 9, 533-542.
18. Carr, V. (1988). Patients' techniques for coping with schizophrenia: An exploratory study. British Journal of Medical Psychology, 61, 339-352.
19. Clinical Standards Board for Scotland (2002). Standards/Mental Health/Schizophrenia. Available from: URL: http.//www.clinicalstandards.org
20. Cohen, C. I. & Berk, L. A. (1985). Personal coping styles of schizophrenic outpatients. Hospital and Community Psychiatry, 36, 407-410.
21. Crow, T. J., Macmillan, J. F., Johnson, A. L. & Johnstone, E. C. (1986). A randomised controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120-127.
22. David, A. S. (1990). Insight and psychosis. British Journal of Psychiatry, 156, 798-808.
23. Docherty, J. P., Kammen, D. P., Siris, S. G. & Marder, S. R. (1978). Stages of onset of schizophrenic psychosis. American Journal of Psychiatry, 135, 420-426.
24. Evers, S. M. A. A., Wiersma, D. & Ament, A. J. H. A. (1995). Kosten van schizofrenie in Nederland [Costs of schizophrenia in The Netherlands]. In P. M. A. J. Dingemans et al. (Ed.). Schizofrenie Onderzoek En Implicaties Voor de Behandeling [Schizophrenia Research and Implications for Treatment] (pp. 290-299). Houten/Diegem: Bohn Stafleu Van Loghum (in Dutch).
25. Falloon, I. R. H. (1987). Cognitive and behavioural interventions in the self control of schizophrenia. In J. S. Strauss, W. Böker & H. D. Brenner (Eds). Psychosocial Treatment of Schizophrenia (pp. 180-190). Toronto: Hans Huber Publishers.
26. Gaebel, W., Frick, U., Kopeke, W. et al. (1993). Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse? British Journal of Psychiatry, 163 (Suppl. 21), 8-12.
27. Gaebel, W., Janner, M., Frommann, N. et al. (2002). First vs multiple episode schizophrenia: two-year outcome of inter-mittent and maintenance medication strategies. Schizophrenia Research, 53, 145-159.
28. Gilbert, P. L., Harris, M. J., McAdams, L. A. & Jeste, D. V. (1995). Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Archives of General Psychiatry, 52, 173-188.
29. Hamera, E., Peterson, K. A., Young, L. M. & McNary Schaumloffel, M. (1992). Symptom monitoring in schizophrenia: potential for enhancing self-care. Archives of Psychiatric Nursing, 6, 324-330.
30. Heinrichs, D. W. & Carpenter, W. T. (1985). Prospective study of prodromal symptoms in schizophrenic relapse. American Journal of Psychiatry, 3, 371-373.
31. Heinrichs, D. W., Cohen, B. P. & Carpenter, W. T. (1985). Early insight and the management of schizophrenic decompensation. The Journal of Nerv and Mental Disease, 3, 133-138.
32. Henmi, Y. (1993). Prodromal symptoms of relapse in schizophrenic outpatients: retrospective and prospective study. The Japan Journal of Psychiatry and Neurology, 4, 753-775.
33. Hert, M. A. F. d. & Slooff, C. J. (2000). Psychopharmacologische behandeling van schizofrenie en aanverwante psychosen [Psychopharmacological treatment of schizophrenia and related psychoses. In G. Pieters et al. (Ed.). Rehabilitation Strategies for Schizophrenia and Longterm Dependent Patients] (pp. 70-84). Houten/Diegem: Bohn Stafleu Van Loghum.
34. Herz, M. I., Glazer, W., Mirza, M., Mostert, M. * Hafez, H. (1989). Treating prodromal episodes to prevent relapse in schizophrenia. British Journal of Psychiatry, 155 (Suppl. 5), 123-127.
35. Herz, M. I., Glazer, W. M., Mostert, M. A. et al. (1991). Intermittent vs maintenance medication in schizophrenia. Archives of General Psychiatry, 48, 333-339.
36. Herz, M. I. & Lamherti, J. S. (1995). Prodromal symptoms and relapse prevention in schizophrenia. Schizophrenia Bulletin, 4, 541-551.
37. Herz, M. I., Lamberti, J. S., Mintz, J., Scott, R., O'Dell, S. P., McCartan, L. & Nix, G. (2000). A program for relapse prevention in schizophrenia: a controlled study. Archives of General Psychiatry, 57, 277-283.
38. Herz, M. I. & Melville, C. (1980). Relapse in schizophrenia. American Journal of Psychiatry, 7, 801-805.
39. Herz, M. I., Szymanski, H. V. & Simon, J. C. (1982). Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication. American Journal of Psychiatry, 139, 918-922.
40. Hirsch, S. R. & Jolley, A. G. (1989). The dysphoric syndrome in schizophrenia and its implications for relapse. British Journal of Psychiatry, 155 (Suppl. 5), 46-50.
41. Holmes, H., Ziemba, J., Evans, T. & Williams, C. A. (1994). Nursing model of psychoeducation for the seriously mentally ill patient. Issues in Mental Health Nursing, 15, 85-104.
42. Inderbitzin, L. B., Lewine, R. R. J., Scheller-Gilkey, G. et al. (1994). A double-blind dose-reduction trial of fluphenazine decanoate for chronic unstable schizophrenic patients. American Journal of Psychiatry, 151, 753-1759.
43. Jolley, A. G., Hirsch, S. R., Morrison, E., McRink, A. & Wilson L. (1990). Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years. British Medical Journal, 301 (Oct), 837-842.
44. Jorgensen, P. (1998). Early signs of psychotic relapse in schizophrenia. British Journal of Psychiatry, 172, 327-330.
45. Kennedy, M. G., Schepp, K. G. & O'Connor, F. W. (2000). Symptom self-management and relapse in schizophrenia. Archives of Psychiatric Nursing, 14, 266-275.
46. Kissling, W. (1991). Guidelines for Neuroleptic Relapse Prevention in Schizophrenia. Heidelberg: Springer-Verlag.
47. Kissling, W. (1992). Ideal and reality of neuroleptic relapse prevention. British Journal of Psychiatry, 161 (Suppl. 18), 133-139.
48. Kumar, S., Thara, R. & Rajkumar, S. (1989). Coping with symptoms of relapse in schizophrenia. European Archives of Psychiatrics Neurological Science, 239, 213-215.
49. Liberman, R. P. & Kopelowicz, A. (1995). Basic elements in biobehavioral treatment and rehabilitation of schizophrenia. International Clinical Psychopharmacology, 9, 51-58.
50. Linszen, D., Dingemans, P., Does, J. W. V. D. et al. (1996). Treatment, expressed emotion and relapse in recent onset schizophrenic disorders. Psychological Medy, 26, 333-342.
51. Malla, A. K. & Norman, R. M. G. (1994a). Prodromal symptoms in schizophrenia. British Journal of Psychiatry, 164, 487-493.
52. Malla, A. K. & Norman, R. M. G. (1994b). Prodromal symptoms in schizophrenia: a prospective investigation. British Journal of Psychiatry, 164, 487-493.
53. Marder, S. R., Mintz, J., Putten, T., Lebell, M., Wirshing, W. C. & Johnston-Cronk, K. (1991). Early prediction of relapse in schizophrenia: An application of receiver operating characteristics (ROC) methods. Psychopharmacology Bulletin, 27, 79-82.
54. Marder, S. R., Wirshing, W. C., Mintz, J. et al. (1996). Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry, 153, 1585-1592.
55. Marder, S. R., Wirshing, W., Putten, T. V. et al. (1994). Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia. Archives of Genera Ppsychiatry, 51, 280-287.
56. McCandless-Glimcher, L., McKnight, S., Hamera, E., Smith, B. L., Peterson, K. A. & Plumlee, A. A. (1986). Use of symptoms of schizophrenics to monitor and regulate their illness. Hospital and Community Psychiatry, 37, 929-933.
57. McEvoy, J. P., Freter, S., Everett, G. et al. (1989). Insight and the clinical outcome of schizophrenic patients. The Journal of Nervous and Mental Disease, 1, 48-51.
58. Meijel, B. V., Gaag, M. V. D., Kahn, R. S. & Grypdonck, M. (2002a). The practice of early recognition and early intervention to prevent psychotic relapse in patients with schizophrenia: an exploratory study. Part 1. Journal of Psychiatric and Mental Health Nursing, 9, 347-356.
59. Meijel, B. V., Gaag, M. V. D., Kahn, R. S. & Grypdonck, M. (2002b). The practice of early recognition and early intervention to prevent psychotic relapse in patients with schizophrenia: an exploratory study. Part 2. Journal of Psychiatric and Mental Health Nursing, 9, 357-364.
60. Meijel, B. V. & Lendemeijer, B. (1997). Ziekte-inzicht bij patienten met schizofrenie [Insight in patients with schizophrenia]. TVZ, 8, 228-232 (in Dutch).
61. Mierlo, F. v. (1997). Vroege voortekenen van een psychose. [Early warning signs of psychosis]. Utrecht: Trimbosinstitute (in Dutch).
62. Murphy, M. F. & Moller, M. (1993). Relapse management in neurobiological disorders. The Moller-Murphy Symptom Management Assessment Tool. Archives of Psychiatric Nursing, 7, 226-235 (in Dutch).
63. Norman, R. M. G. & Malla, A. K. (1995). Prodromal symptoms of relapse in schizophrenia: a review. Schizophrenia Bulletin, 4, 527-539.
64. Novacek, J. & Raskin, R. (1998). Recognition of warning signs: a consideration for cost-effective treatment of severe mental illness. Psychiatric Services, 49, 376-378.
65. Nuechterlein, K. H. & Dawson, M. E. (1984). A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bulletin, 10, 300-312.
66. Nuechterlein, K. H., Dawson, M. E., Gitlin, M. et al. (1992). Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr Bulletin, 18, 387-425.
67. Nuechterlein, K. H., Dawson, M. E., Ventura, J. et al. (1994). The vulnerability/stress model of schizophrenic relapse: a longitudinal study. Acta Psychiatrica Scandinavica, 89, 58-64.
68. O'Connor, F. W. (1991). Symptom monitoring for relapse prevention in schizophrenia. Archives of Psychiatric Nursing, 5, 193-201.
69. Pietzcker, A., Gaebel, W., Kopcke, W. et al. (1993). Intermittent versus maintenance neuroleptic long-term treatment in schizophrenia - 2-year results of a German multicenter study. Journal of Psychiatric Research, 27, 321-339.
70. Rice, D. P. (1999). The economic impact of schizophrenia. Journal of Clinical Psychiatry, 60, 4-6.
71. Schooler, N. R., Keith, S. J., Severe, J. B. et al. (1997). Relapse and rehospitalization during maintenance treatment of schizophrenia. Archives of General Psychiatry, 54, 453-463.
72. Schooler, N. R., Keith, S. J., Severe, J. B. & Matthews, S. M. (1995). Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies. Psychiatrics Quarterly, 66, 279-292.
73. Stenberg, J. H., Jaaskelainen, I. P. & Royks, R. (1998). The effect of symptom self-management training on rehospitalization for chronisc schizophrenia in Finland. International Review of Psychiatry, 10, 58-61.
74. Subotnik, K. L. & Nuechterlein, K. H. (1988). Prodromal signs and symptoms in schizophrenic relapse. Journal of Abnormal Psychology, 97, 405-411.
75. Tarrier, N., Borrowclough, C. & Bamrah, J. S. (1991). Prodromal signs of relapse in schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 26, 157-161.
76. Viguera, A. C., Baldessarini, R. J., Hegarty, J. D., Kammen, D. P. & Tohen, M. (1997). Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Archives of General Psychiatry, 54, 49-55.
77. Vries, M. W. & d. & Delespaul, Ph (1988). Variabiliteit in schizofrenie symptomatologie [Variability in schizophrenic symptomatology]. In R. J. van den Bosch, C. R. van Meer, P. M. A. J. Dingemans & D. H. Linszen (Eds). Schizofrenie: Recente Ontwikkelingen in Onderzoek En Behandeling [Schizophrenia: Recent Developments in Research and Treatment] (pp. 203-228). Deventer: Van Loghum Slaterus (in Dutch).
78. Wallace, C. J., Liberman, R. P., MacKain, S. J., Blackwell, G. & Eckman, T. A. (1992). Effectiveness and replicability of modules for teaching social and instrumental skills to the severe mentally ill. American Journal of Psychiatry, 149, 654-658.
79. Westacott, M. (1995). Strategies for managing auditory hallucinations. Nurs Times, 3, 35-37.
80. Wing, J. K. (1978). The social context of schizophrenia. American Journal of Psychiatry, 135, 1333-1339.
81. Wirshing, W. C., Eckman, T. A., Liberman, R. P. & Marder, S. R. (1991). Management of risk of relapse through skills training of chronic schizophrenics. In C. A. Tamminga & S. C. Schulz (Eds). Advances in Neuropsychiatry and Psychopharmacology, Vol. 1: Schizophrenia Research (pp. 255-267). New York: Raven Press.
82. Zubin, J. & Spring, B. (1977). Vulnerability. A new view of schizophrenia. Journal of Abnormal Psychology, 86, 103-126.
83. Zubin, J., Steinhauer, S. R. & Condray, R. (1992). Vulnerability to relapse in schizophrenia. British Journal of Psychiatry, 161, 13-18.